BML 4.97 Decreased By ▼ -0.04 (-0.8%)
BOP 13.11 Increased By ▲ 0.03 (0.23%)
CNERGY 7.21 Increased By ▲ 0.09 (1.26%)
CPHL 86.40 Decreased By ▼ -1.05 (-1.2%)
DCL 14.40 Increased By ▲ 0.06 (0.42%)
DGKC 170.39 Decreased By ▼ -0.37 (-0.22%)
FCCL 46.56 Decreased By ▼ -0.20 (-0.43%)
FFL 15.99 Increased By ▲ 0.17 (1.07%)
GCIL 26.70 Decreased By ▼ -0.17 (-0.63%)
HUBC 148.35 Increased By ▲ 4.17 (2.89%)
KEL 5.33 Increased By ▲ 0.26 (5.13%)
KOSM 6.52 Decreased By ▼ -0.17 (-2.54%)
LOTCHEM 20.56 Decreased By ▼ -0.03 (-0.15%)
MLCF 85.00 Increased By ▲ 0.27 (0.32%)
NBP 126.90 Increased By ▲ 5.08 (4.17%)
PAEL 43.19 Decreased By ▼ -0.27 (-0.62%)
PIAHCLA 22.40 Increased By ▲ 0.11 (0.49%)
PIBTL 8.95 Increased By ▲ 0.02 (0.22%)
POWER 14.01 No Change ▼ 0.00 (0%)
PPL 169.00 Decreased By ▼ -0.94 (-0.55%)
PREMA 42.65 Decreased By ▼ -0.74 (-1.71%)
PRL 33.30 Increased By ▲ 0.19 (0.57%)
PTC 24.10 Decreased By ▼ -0.16 (-0.66%)
SNGP 118.80 Decreased By ▼ -0.84 (-0.7%)
SSGC 46.20 Increased By ▲ 0.65 (1.43%)
TELE 8.25 Increased By ▲ 0.17 (2.1%)
TPLP 10.40 Decreased By ▼ -0.07 (-0.67%)
TREET 23.87 Decreased By ▼ -0.10 (-0.42%)
TRG 58.35 Increased By ▲ 0.30 (0.52%)
WTL 1.55 Increased By ▲ 0.03 (1.97%)
BR100 13,880 Increased By 249.5 (1.83%)
BR30 40,209 Increased By 358.4 (0.9%)
KSE100 136,503 Increased By 2202.8 (1.64%)
KSE30 41,553 Increased By 738.3 (1.81%)

LONDON: Nestle posted lower-than-expected nine-month sales growth on Thursday as higher product prices made shoppers balk and hurt volumes.

Organic sales, which exclude the impact of currency movement and acquisitions, rose 7.8% in the nine months ended September, the maker of Maggi stock cubes and Nescafe coffee said. Analysts had on average expected organic sales growth of 8.1%.

Total reported sales decreased by 0.4% to 68.8 billion Swiss francs ($76.54 billion).

Nestlé Pakistan launches campaign on goodness of food

Nestle’s 8.4% price increase was below the average analyst estimate of 8.6%.

Real internal growth - or a measure of sales volumes - fell 0.6%, meeting expectations.

Comments

Comments are closed.